Giant Cell Arteritis (GCA) is a systemic vasculitis
involving medium to large sized vessels most commonly the cranial
branches of the arteries originating from the aortic arch.
It is called temporal arteritis too, because of frequent/
classic involvement of temporal artery in this vasculitis.
All patients are more than 50 years old and women can be
affected much more than men.
The common clinical manifestations of GCA are recent
headache, visual disturbance, polymyalgia rheumatica, jaw
claudication, fever and/or anemia and especially tender and/or
enlarged and/or pulseless temporal artery.
Elevated Erythrocyte Sedimentation Rate (ESR) and
anemia of normocytic/normochromic are common and the biopsy
of temporal artery is the most important procedure within
approaching towards the diagnosis of GCA. Compatible pathology
for GCA is vascular and/or perivascular fibrinoid necrosis along
with leukocyte infiltration and granuloma.
A negative temporal artery biopsy can be seen in up to
one-half of the cases with GCA. As you know, American College
of Rheumatology (ACR) criteria is used for classification of GCA
and it is not diagnostic. By this letter, the corresponding author
wants to deliver a new criteria for early diagnosis of this disease.
Keywords: Giant Cell Arteritis; Temporal Arteritis; ACR
Criteria; ACR Revised Criteria
Open Access
Peer Reviewed
ISSN: 2378-6337
Autoimmune Diseases and Therapeutic Approaches
International open-access publishing for high-quality research, reviews, case studies, and scholarly communication.
Submit Manuscript
Original Research
Article in Press
2016 ACR Revised Criteria for Early Diagnosis of Giant Cell (Temporal) Arteritis
Iraj Salehi-Abari
Corresponding Author: Iraj Salehi-Abari
Received: Apr 13, 2016
Accepted: Apr 18, 2016
Published: Apr 21, 2016
Views: 4
DOI: N/A
Abstract
Iraj Salehi-Abari (2016), 2016 ACR revised criteria for early diagnosis of Giant Cell (Temporal) Arteritis. Autoimmune Dis Ther
Approaches 2016, 3:1
Copyright:
Copyright: © 2016 ADTAOA. This is an open-access article distributed under the terms of the Creative Commons Attribution License, Version 3.0, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Indexed In
Google Scholar
DOAJ
PubMed
Scopus